http://www.in-pharmatechnologist.com/Drug-Delivery/No-improv...
Risk of prescription being mis-filled: "An estimated 51.5 million errors occur during the filling of 3 billion prescriptions each year."
http://www.ncbi.nlm.nih.gov/pubmed/12688437?dopt=Abstract
Risk of manufacturing error in prescription drugs: "Dr. Collazo recently worked with a drug manufacturer that had a baseline rate of 4.7 errors per thousand units manufactured."
http://www.fdanews.com/humanerrordrugdevice
Risk of ??????: "Three batches of Nurofen Plus in pharmacies in south London have been found to contain another drug, Seroquel XL 50mg, which is manufactured by AstraZeneca – a completely separate drug company."
http://metro.co.uk/2011/08/25/nurofen-plus-containing-antips...
I think even folks over at Erowid advise caution in dealing with these things. In that regard, conflating legal risk & qualitative risk isn't really a non sequitur. That's really all I was trying to say.
Although I don't have evidence either way, my suspicion is that this results in a comparatively low risk in truth. It's not immediate that the legal status impacts on the risk at all.
The mis-prescriptions were for infirm elderly patients, who I suspect wouldn't do great on LSD either.
Unless you synthesized it yourself or have the ability to analyze it in a lab, you absolutely cannot be certain of quality or authenticity. This is what legally enforced regulatory standards are all about ensuring. The illegal nature of the drug trade not only lacks provision for that, it influences and informs the behavior of participants on the supply side for economic reasons too.
In a logical vacuum, yes, it is a legal risk. In practical application, the legal risk is often correlated with the quality risk too.